Autoinjectable PCSK9 Inhibitor; Caution on CoQ10; Ohio Doc's Rape Charges
(MedPage Today) -- The FDA approved the autoinjector version of lerodalcibep (Lerochol), a PCSK9 inhibitor for LDL cholesterol lowering, LIB Therapeutics announced. Bracco Imaging announced FDA clearance of its VueJect contrast delivery system...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.